SSelectStock

INDGNIndegene Limited

Healthcare · Health Information Services · NSE · as of 2026-09-11 (delayed ~30 min in market hours)

Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technology platforms. Further, it provides analytics, technology, commercial, medical, regulatory, and safety services to life science and healthcare organizations. Indegene Limited was incorporated in 1998 and is based in Bengaluru, India.

578.35
0.17%
68Decent

Mkt Cap
₹13,931 Cr
P/E
34.8
P/B
4.5
Div Yield
0.00%
52W High
₹615.50
52W Low
₹414.00

Price & Volume

Loading chart…

Key Ratios

Market Cap (₹ cr)13,930.70
P/E34.84
P/B4.47
PEG
ROE %13.94
ROCE %15.00
Debt / Equity0.05
EPS16.60
Revenue Growth %32.80
Profit Growth %-32.30
Dividend Yield %0.00
Promoter Holding %55.67
FII Holding %20.67
DII Holding %
Beta0.73

“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.

Active Pattern Signals

None of the 16 pattern scanners currently detects a setup on INDGN — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.

HOLDConviction 75%

The picture

  • Revenue growth: 32.8% YoY
  • Debt/Equity: 0.05
  • Promoter holding: 55.7%
  • RSI: 53
  • Price vs SMA50: above
  • Price vs SMA200: above

Bull case

  • Revenue growth: 32.8% YoY
  • Debt/Equity: 0.05
  • Promoter holding: 55.7%
  • RSI: 53

Bear case

  • Profit growth: -32.3% YoY
  • Dividend yield: 0.00%
  • MACD: bearish
  • Price vs EMA21: below

Key risks

  • Profit growth: -32.3% YoY
  • Dividend yield: 0.00%

Algorithmic analysis for research only — not SEBI-registered investment advice.

Trade Plan

Entry (CMP)
₹578.35
Stop Loss
₹547.97
risk 5.3%
Target 1 (1.5R)
₹623.93
+7.9%
Target 2 (3R)
₹669.50
+15.8%
Support (20d)
₹553.50
Resistance (52w)
₹615.50
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹30.38/share
ATR (volatility)
₹16.28
avg daily range

Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹16.28). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.

Score Breakdown

Fundamental65
Technical59
Momentum78
Risk (safety)78

Peers — Healthcare

GKSL 1.23%
79
NEPHROPLUS 2.42%
74
KOVAI 1.41%
73
SAILIFE 0.38%
73
METROPOLIS 1.70%
73
VIJAYA 0.21%
72